Clinical Trials Directory

Trials / Completed

CompletedNCT01230632

Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques

Metabolic Phenotyping of Individuals Born Following Assisted Reproduction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Adelaide · Academic / Other
Sex
All
Age
16 Years – 26 Years
Healthy volunteers
Accepted

Summary

This study is to compare the effects of high fat overfeeding on metabolic risk factors in children born though assisted reproduction technologies (ART) versus children conceived naturally (controls). The investigators will utilize state of the ART measures to characterize the physiological, endocrine and molecular responses to high fat overfeeding. The investigators hypothesize that children conceived following ART will have greater responses to high fat dietary challenge and that this will be associated with DNA hypermethylation of genes that are involved in lipid metabolism.

Detailed description

This study represents a novel initiative by the investigators to determine whether children conceived through ART have different metabolic responses at baseline or in response to high fat overfeeding as compared to age and body mass index-matched spontaneously conceived controls. Furthermore, the investigators will identify any differences in DNA methylation of candidate genes involved in lipid metabolism in adipose tissue and blood, to determine whether this is related to adverse outcomes during high fat overfeeding. The results from this study will help answer growing questions of the future health of In vitro fertilisation (IVF) babies, and may stimulate further research into optimising protocols for ovarian stimulation or in-vitro conditions during early blastocyst development.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENThigh fat overfeedingDietary Supplement:3 days overfeeding

Timeline

Start date
2010-09-01
Primary completion
2013-04-01
Completion
2013-09-01
First posted
2010-10-29
Last updated
2013-12-10

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01230632. Inclusion in this directory is not an endorsement.